Abstract
The antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) were compared with those of five similar compounds and four comparison drugs against 103 strains of Legionella pneumophila and five other Legionella species type strains. When concentrations inhibiting 90% of strains tested (MIC90s) for L. pneumophila were determined, CI-960 and temafloxacin emerged as the most active (0.015 microgram/ml) and were followed in potency by E4695 (0.03 microgram/ml). This activity was two- to fourfold greater than that of the reference drug, ciprofloxacin, and approached that of rifampin (MIC90, 0.008 microgram/ml). All fluoroquinolones studied were more active than erythromycin (MIC90, 0.5 microgram/ml). These two investigational fluoroquinolones appear well suited for further in vivo study of legionellosis therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barker J., Farrell I. D. The effect of charcoal on MICs for Legionella. J Antimicrob Chemother. 1986 Jan;17(1):127–127. doi: 10.1093/jac/17.1.127. [DOI] [PubMed] [Google Scholar]
- Cohen M. A., Huband M. D., Mailloux G. B., Yoder S. L., Roland G. E., Heifetz C. L. In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):245–258. doi: 10.1016/0732-8893(91)90039-i. [DOI] [PubMed] [Google Scholar]
- Easmon C. S., Crane J. P. Uptake of ciprofloxacin by human neutrophils. J Antimicrob Chemother. 1985 Jul;16(1):67–73. doi: 10.1093/jac/16.1.67. [DOI] [PubMed] [Google Scholar]
- Garraffo R., Jambou D., Chichmanian R. M., Ravoire S., Lapalus P. In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils. Antimicrob Agents Chemother. 1991 Nov;35(11):2215–2218. doi: 10.1128/aac.35.11.2215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hardy D. J., Swanson R. N., Hensey D. M., Ramer N. R., Bower R. R., Hanson C. W., Chu D. T., Fernandes P. B. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrob Agents Chemother. 1987 Nov;31(11):1768–1774. doi: 10.1128/aac.31.11.1768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Havlichek D., Saravolatz L., Pohlod D. Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila. Antimicrob Agents Chemother. 1987 Oct;31(10):1529–1534. doi: 10.1128/aac.31.10.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Helms C. M., Massanari R. M., Zeitler R., Streed S., Gilchrist M. J., Hall N., Hausler W. J., Jr, Sywassink J., Johnson W., Wintermeyer L. Legionnaires' disease associated with a hospital water system: a cluster of 24 nosocomial cases. Ann Intern Med. 1983 Aug;99(2):172–178. doi: 10.7326/0003-4819-99-2-172. [DOI] [PubMed] [Google Scholar]
- Jones R. N. Activity of sparfloxacin (AT-4140), PD127391 and PD131628 against Legionella spp. J Antimicrob Chemother. 1991 Mar;27(3):389–390. doi: 10.1093/jac/27.3.389. [DOI] [PubMed] [Google Scholar]
- Jones R. N., Aldridge K. E., Barry A. L., Fuchs P. C., Gerlach E. H., Pfaller M. A., Washington J. A., 2nd Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing. Diagn Microbiol Infect Dis. 1988 Aug;10(4):221–240. doi: 10.1016/0732-8893(88)90094-6. [DOI] [PubMed] [Google Scholar]
- Jones R. N. In vitro evaluation of E-4695, a new fluoro-naphthyridine. Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):188–194. doi: 10.1007/BF01967076. [DOI] [PubMed] [Google Scholar]